Drug delivering contact lenses win MIT’s top healthcare innovation prize

Contact lenses that deliver medications directly to the eye over a period of days or weeks were the recent grand prize winner of the Massachusetts Institute of Technology’s Sloan Healthcare Innovation Prize. The MIT Sloan Healthcare Innovation Prize competition had 8 finalists who pitched their healthcare innovations to judges from Optum and other local venture

Covestro releases new polycarbonate with resistance to solvents, cleaning agents

Covestro has released Makrolon Rx3440, a material designed to withstand solvents found in oncology treatments — as well as cleaning agents. The medical polycarbonate offers durability and chemical resistance to help prevent cracking so that healthcare professionals can more safely deliver oncology drugs to patients. Cancer treatments are hard on plastics, noted Lauren Zetts, North America

The most disruptive medical device innovations of all time

When it comes to disruptive medical device innovations, it’s easy to lose the perspective of history. Here are devices through history that definitely made a difference. Chris Newmarker, Managing Editor and Danielle Kirsh, Assistant Editor Whether you’re talking about surgical robotics or efforts to bring more value to healthcare, the word “disruptive” seems to get

Pages: 1 2 3 4 5 6 7 8

How self-serve medical devices could make patients feel in control

Intimidating medical devices can cause anxiety for patients — in the same way that people can experience “white coat hypertension” when seeing a doctor. Devices that are smaller and more patient-centered could help patients feel better about their treatment and make them feel like they’re in charge, according to Leslie Trigg, CEO at Outset Medical (San

Medtronic expands insulin pump portfolio with MiniMed Mio infusion set

Medtronic (NYSE:MDT) has launched its MiniMed Mio Advance infusion sets, which are designed for people managing their diabetes with insulin pump therapy. The medtech titan touted its product, which was developed by ConvaTec, as boasting a user-friendly design that allows patients to access hard-to-reach sites, like the lower back. The infusion system has no visible needle […]

17 black innovators who made medtech better

From cardiology to endoscopy to blood transfusion, African Americans have played an important role as innovators in the history of medicine and medtech. To help mark African American History Month, here’s a look at some of their greatest achievements. Here are 17 black innovators who have made discoveries and invented devices to make medtech better.

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Agilent inks incubator deal with USC

Agilent Technologies announced that it has formed a scientific collaboration with the University of Southern California Michelson Center for Convergent Bioscience. The collaboration will help create an Agilent Center of Excellence in Biomolecular Characterization. The new center will be located in Michelson Hall at USC. The research facility will help establish a convergence of researchers

The 5 biggest issues in patenting combo products

Complexity and ownership issues make combination products a patenting labyrinth. Here are five key points to help you navigate the maze. David J. Dykeman and Roman Fayerberg, Greenberg Traurig The rise of personalized medicine has spurred another trend: the growth of combination products that blend biologics, drugs and medical devices to improve patient treatment. However,

The ‘smart pill’ market could be worth $3B by 2025: Meet the key players

The “smart pill” market is expected to nearly quadruple in value to $3 billion by 2025, according to Grand View Research. Driving this growth is an increasing demand for minimally-invasive procedures, as well as better patient monitoring capabilities. There are a number of players in the pharmaceutical and medtech arenas looking to stake a claim

Beta Bionics raises $2m

Beta Bionics has raised $2.4 million in a new round of equity and securities financing, according to an SEC filing posted this week. A total of 11 anonymous investors have participated in the round, though the company has not yet stated who has joined or how it plans to spend funds raised. Read the whole […]

Companion Medical launches smart insulin pen in U.S.

Companion Medical started selling its smart insulin pen in the U.S. today, according to the San Diego, Calif.-based company. The InPen system, which combines an insulin injector pen and a smartphone app, is compatible with Eli Lilly‘s (NYSE:LLY) Humalog and Novo Nordisk‘s (NYSE:NVO) Novolog fast-acting insulin. Get the full story at our sister site, Drug Delivery Business News.

Phillips-Medisize, Dance Biopharm ink deal for inhaled insulin device

Privately-held biotech Dance Biopharm and Phillips-Medisize have entered into a joint development deal for a connected drug-delivery device for inhaled insulin. The agreement gives Phillips-Medisize, which already designs and manufactures devices for Dance, the development work for future enhancements of Dance’s devices, as well as commercial manufacturing of the inhaled insulin delivery device when it gets to the market.

These 10 medtech companies care a lot about research

Among the world’s largest medtech companies, these 10 spent the largest portion of their budgets on research and development. So what have they produced? Every year, Medical Design & Outsourcing pulls financial regulatory filings and reaches out to major, companies in some cases to create a list of the 100 largest medical device companies in

Pages: 1 2 3 4 5 6 7 8 9 10 11

Phillips-Medisize showing off respiratory device capabilities at DDL2017

Phillips-Medisize will be exhibiting at the Drug Delivery to the Lungs Conference in Scotland next month, providing a chance to further tout its respiratory device capabilities. The Hudson, Wis.–based contract manufacturer boasts more than 30 years at the forefront of inhalation technology. The company’s experience ranges from feasibility to selecting the right components – all the way through

How to ensure patient centricity in drug-delivery system design

Now more than ever, it’s critical for drug-delivery systems to address usability needs and patient safety. Here are three key takeaways to ensure that patients stay central to the development process for drug-delivery devices. Kennedy Clark, West Pharmaceutical Services For the treatment of many chronic conditions, such as Crohn’s disease, diabetes, multiple sclerosis and rheumatoid arthritis,